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Currently, there is a global drive to promote white (industrial) biotechnology as a central 
technology to enable sustainable economic future of the modern industrialized societies. 
With the increasing shift towards a bio-based economy, there is rising demand for developing 
efficient cell factories that can produce fuels, chemicals, pharmaceuticals, materials, 
nutraceuticals, and even food ingredients. Strain improvement is a requisite for the efficient 
development of biotechnological processes. The genetic improvement of strains should be 
done as close as possible to the industrial conditions in which they will be applied in order to 
guarantee a good performance. An integrative approach for strain and process development 
should be followed. Moreover, the utilisation of renewable resources as substrates should be 
considered not only for the economic point of view but also for the positive impact on 
environment. Molecular biotechnology has been applied in this context for the improvement 
of microbial strains and processes. We have been using targeted metabolic engineering as a 
standard way of strain improvement followed by random metabolic engineering 
approaches[1] together with systems-level analysis of the metabolic characteristics of the 
mutant strains[2]. On the basis of the results of the analysis, further targeted metabolic 
engineering can be performed on random mutant strains for the improvement of their 
metabolic performance. Practical examples of the application of this approach will be given 
for bioethanol and recombinant proteins production.   
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